This notice is given under NZX Listing Rule 3.13.1 and 65(2) of the Companies Act 1993, and relates to the acquisition of ordinary shares in NZME Limited under the on-market share buy-back programme announced by NZME Limited in December 2021.
Soft tissue regeneration company remains debt-free.
Contact is relying on demand increase to fund expansion.
It is the first mid-season cut since 2023.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details